Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

2020161 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet HIV

Volume 7, Issue 7, pp. e472-e481

Field-Weighted Citation Impact: 2.38